Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ESLA

Estrella Immunopharma Inc

Jun 01 • 01:07PM ET

1.08

-0.01 -0.92 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BYSI CING EXOZ FBIO IBIO IBO ICCC IMA IMMP XBIT

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.35	Insider Own	60.61%	Shs Outstand	42.67M	Perf Week	-6.90%
Market Cap	46.48M	Forward P/E	-	EPS next Y	-	Insider Trans	0.01%	Shs Float	17.25M	Perf Month	-34.15%
Enterprise Value	44.55M	PEG	-	EPS next Q	-	Inst Own	12.15%	Short Float	0.55%	Perf Quarter	-5.26%
Income	-13.25M	P/S	-	EPS this Y	-	Inst Trans	0.06%	Short Ratio	1.12	Perf Half Y	-42.55%
Sales	0.00M	P/B	-	EPS next Y	-	ROA	-434.36%	Short Interest	0.09M	Perf YTD	-30.77%
Book/sh	-0.12	P/C	24.08	EPS next 5Y	-	ROE	-314.60%	52W High	3.15 -65.71%	Perf Year	6.97%
Cash/sh	0.04	P/FCF	-	EPS past 3/5Y	-27.10% -70.08%	ROIC	-	52W Low	0.78 38.46%	Perf 3Y	-89.93%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.44% 8.80%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-22.50%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.24	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	32.86	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.24	EPS Q/Q	6.53%	SMA20	-10.19%	Beta	0.85	Target Price	12.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-21.07%	Rel Volume	0.45	Prev Close	1.09
Employees	-	LT Debt/Eq	-	Earnings	Feb 25	SMA200	-24.46%	Avg Volume	83.90K	Price	1.08
IPO	Sep 14, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	22.22% -	Trades		Volume	21,900	Change	-0.92%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)